Northern DE Chapter: November 18th Dinner Meeting
Hilton Wilmington/Christiana
100 Continental Drive
Newark, DE 19713
Thursday, November 18, 2021 at 6:00pm ET - 8:00pm ET
This event has ended.
Info
Topic
Exploring the Benefits of BREZTRI: AstraZeneca’s Triple Therapy Treatment
Speaker(s)
Dr. Victor Banzon Pulmonologist, Beebe HealthCare
Attachments
Additional Information
COPD flare-up protection. BREZTRI AEROSPHERE combines three medicines in one inhaler—an inhaled corticosteroid (ICS) medicine (budesonide), an anticholinergic medicine (glycopyrrolate), and a long-acting beta2-adrenergic agonist (LABA) medicine (formoterol fumarate)—that could* help your patients breathe better and improve their COPD symptoms. When used long term, BREZTRI is proven to protect against COPD flare-ups. In fact, BREZTRI is the first and only COPD medicine proven to reduce COPD flare-ups by 52 percent†.